Medical, Health, & Pharmacy News Headlines

Pharmacy News Archives

Medical News Today
EurekAlert!
Univ. of Maryland
Medbroadcast.com
Reuters Health/Medical
New York Times Health
BBC Health & Medical
PRWeb Pharmaceuticals

Popular Medications

Weight Loss & Diet
Pain Relief
Men's Health
Women's Health
Skin Care
Quit Smoking
Sexual Health
Muscle Relaxants
Allergy Relief
Anti-depressants
Anxiety
Sleep Aids
Gastro-intestinal

Insurance & Litigation

Viatical Settlement

Tools & Information

Currency Converter
Resource Directory
Pharmacy Affiliate

 Back to Medical News Today Archives



Medical News Today: 12-18-2004

All Over 50s Should Get Flu Shot - CDC's Advisory Committee
Adults aged 50-64 and close contacts of persons in high-risk groups will be eligible for influenza vaccination in areas where vaccine supply is sufficient to meet demand - Today, the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) expanded the list of priority groups recommended to receive inactivated influenza vaccine this flu season, depending on the availability of influenza vaccine in state or local health jurisdictions... click link for more info.

ANC accuses US of using Africans to promote nevirapine AIDS drug
Thabo Mbeki's ruling party of South Africa, the ANC (African National Congress), has attacked top US officials and accused them of using African women and babies as human guinea pigs to promote nevirapine, a controversial AIDS drug... click link for more info.

Lunesta (Eszopiclone) Approved by FDA for Treatment of Insomnia
Sepracor Inc (Nasdaq: SEPR) today announced that the US FDA has approved the New Drug Application (NDA) for LUNESTA(TM) brand eszopiclone, formerly referred to as ESTORRA, 1 mg, 2 mg and 3 mg tablets for the treatment of insomnia... click link for more info.

Typhoid fever in Democratic Republic of the Congo
WHO has received reports of a significant, ongoing outbreak of typhoid fever in Kinshasa... click link for more info.

Fleeting Images of Fearful Faces Reveal Neurocircuitry of Unconscious Anxiety
Researchers at Columbia University Medical Center have found that fleeting images of fearful faces - images that appear and disappear so quickly that they escape conscious awareness - produce unconscious anxiety that can be detected in the brain with the latest neuroimaging machines... click link for more info.

Case announces launch of gene expression analysis software
Case Western Reserve University has announced that its BAMarrayTM software is now available for download and licensing... click link for more info.

Vaccine for Diabetes to Get Human Test in Britain Next Year
A promising vaccine against the worst form of diabetes will be tested on humans in Britain next year... click link for more info.

Bad news about Celebrex, Strattera, Iressa fuel criticisms of FDA
A string of negative reports about medications has the media buzzing with questions about the job FDA is doing and the public asking pharmacists and physicians questions about whether the drugs they are taking are really safe and effective... click link for more info.

Medical revalidation scheme to be reviewed, UK
The UK government has decided to review the GMC's proposed new system of revalidation in the light of Dame Janet Smith's 5th report on the Shipman case... click link for more info.

Further measures to slash NHS red tape, UK
More central data collections scrapped or reduced, saving the NHS an estimated £7... click link for more info.

New guide to combat heart disease in the South Asian community, UK
The Department of Health today published a guide aimed at cutting Coronary Heart Disease (CHD) in the South Asian Community... click link for more info.

FDA Statement on the Halting of a Clinical Trial of the Cox-2 Inhibitor Celebrex
The FDA today released the following statement on the halting of a clinical trial of the Cox-2 inhibitor Celebrex (celecoxib): The Food and Drug Administration (FDA) learned last night from the National Cancer Institute (NCI) and Pfizer, Inc... click link for more info.

New FDA Warning for Strattera, drug for ADHD
The Food and Drug Administration (FDA) is advising health care professionals about a new warning for Strattera, a drug approved for attention deficit hyperactivity disorder (ADHD) in adults and children... click link for more info.

FDA Statement on Iressa for patients with lung cancer
The FDA today released the following statement regarding the failure of a clinical trial of Iressa (gefitinib) to show an overall survival advantage in treating patients with lung cancer: The Food and Drug Administration (FDA) learned yesterday from AstraZeneca that a large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer who had failed other courses of cancer therapy showed no survival benefit from taking Iressa... click link for more info.

Singapore Hospitals Begin Testing Pregnant Women for HIV - Many Opt Out
Singapore hospitals on Dec... click link for more info.

Doctors, AIDS Advocates Concerned African Governments Will Halt Nevirapine Use
Doctors and HIV/AIDS advocates in Africa are concerned that their governments will halt the use of the antiretroviral drug nevirapine to prevent mother-to-child HIV transmission because of recent reports that have raised questions about the drug's safety in pregnant women, the AP/USA Today reports (Muleme, AP/USA Today, 12/17)... click link for more info.

Millions of High-Risk People Failed To Receive Flu Shot, Officials Say
The CDC's Advisory Committee on Immunization Practices on Friday will meet to consider easing its recommendations on who should receive flu vaccinations as a new survey finds that only 34... click link for more info.

Risk of Tuberculosis Doubles in First Year of HIV Infection
The risk of tuberculosis infection doubles within one year of HIV infection, according to a study published in the Jan... click link for more info.

Novartis collaborates with Bayer for EMSELEX® for overactive bladder
Novartis announces commercialization collaboration in Germany for EMSELEX® in the treatment of overactive bladder - Novartis Pharma AG announced today the start of a collaboration between Novartis Pharma GmbH and Bayer Vital AG for the commercialization and distribution of EMSELEX® (darifenacin hydrobromide), 7... click link for more info.

Few Americans are aware they have chronic kidney disease
Ten to 20 million people in the United States have kidney disease but most don't know it, according to researchers at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health, the Johns Hopkins Bloomberg School of Public Health, and the National Center for Health Statistics (NCHS) at the Centers for Disease Control and Prevention... click link for more info.

Discovery of compound could enhance cancer treatments with fewer side effects
The discovery of a new compound by Michigan State University researchers could lead to improved chemotherapy treatments for different types of cancers - potentially with fewer side effects... click link for more info.

Yo-yo diet redistributes toxins in body tissue; Olestra+caloric cut boosts toxic excretion
Perhaps Ukrainian opposition leader Viktor Yushchenko should try an "Olestra diet" to rid his body of dioxin... click link for more info.

Children's anxiety prior to surgery linked to behavioral changes
A child's level of anxiety prior to surgery is predictive of whether they will experience post-surgical delirium and maladaptive behavioral changes, including anxiety, nighttime crying, and bedwetting, according to a Yale study published in the journal Anesthesia & Analgesia... click link for more info.

Your Brain and You: Ethical Challenges Ahead for Neuroscience and Society
Are we ready for a future where brain scans invade our private thoughts? Will we have to alter our brains chemically to keep competitive at our jobs? Could science determine that "souls" do not exist, and, if so, what does that mean for how we think of ourselves as human beings? The cover story in this month edition of the journal Trends in Cognitive Sciences, released today, tackles these questions about the growing influence of neuroscience on 21st-century life... click link for more info.

NIH halts use of COX-2 inhibitor in large cancer prevention trial
The National Institutes of Health (NIH) announced today that it has suspended the use of COX-2 inhibitor celecoxib (Celebrex? Pfizer, Inc... click link for more info.

Preventing A Heart Attack Can Also Prevent Memory Loss
A new study reveals the steps you take to prevent heart attack may also help prevent you from developing dementia... click link for more info.

President Bush Purchases Health Savings Account
President Bush this week established a tax-deferred health savings account despite the fact that, as commander in chief, he receives health care at no cost from the military... click link for more info.

Infection raises stroke risk
Acute infection increases the risk of cardiovascular disease in susceptible individuals, according to new research... click link for more info.

Bracelets can 'ease' arthritis pain
According to a new study, magnetic bracelets can ease pain and discomfort experienced by arthritis sufferers... click link for more info.

Mobile hospitals to tackle alcohol-induced injuries of mad Xmas Brits
Mobile medical units have been set up in two UK cities to deal with alcohol-related injuries... click link for more info.

Heart monitors 'could prevent' epilepsy deaths
Cardiac pacemakers could help prevent unexpected epilepsy deaths in some sufferers, a new study suggests... click link for more info.

Women waiting longer to give birth, UK
Women in Britain are choosing to have children later than ever, according to a new report... click link for more info.

Statement from the GMC on the Dept of Health review, UK
This is a statement from the General Medical Council (GMC) "We warmly welcome the review into the findings of the Shipman Inquiry, and in particular on revalidation... click link for more info.

How many Americans have had flu shot so far?
Because of the unexpected reduction in the amount of available inactivated influenza vaccine for the 2004--05 influenza season, on October 5, 2004, the Advisory Committee on Immunization Practices (ACIP) recommended that the vaccine be reserved for persons in certain priority groups and asked others to defer or forego vaccination (1)... click link for more info.

Recent reclassifications of medicines, MHRA, UK
Recent reclassifications of medicines include: -- Diclofenac 1% topical gel (P (pharmacy) to GSL (general sale list) -- MHRA guidance on the management of paracetamol overdose updated-- MHRA guidance on the minimum clinical particulars for P and GSL oral ibuprofen products updated-- A spray preparation containing hydrocortisone 0... click link for more info.

Wine and chocolate help you live longer and better
A Dutch researchers has found that wine, fish, dark chocolate, fruit and vegetables, garlic and almonds eaten regularly can lower your chances of developing heart disease later in life by 76%... click link for more info.

Salt levels in soups vary greatly
Salt levels in different soups vary widely, according to a survey published today by the Food Standards Agency, UK... click link for more info.

Priority Conditions for Research under Medicare Modernization Act Released
The Agency for Healthcare Research and Quality announced a $15 million initiative that will develop state-of-the-art information about the effectiveness of interventions, including prescription drugs, for 10 top conditions affecting Medicare beneficiaries... click link for more info.

Binge drinking blitz begins, UK
Police will begin a Christmas enforcement campaign on binge-drinking and under-age drinking today... click link for more info.

TAP Submits New Drug Application for Febuxostat for Hyperuricemia in Chronic Gout
OSAKA, JAPAN --- Takeda Pharmaceutical Company Limited ("Takeda") announced today that TAP Pharmaceutical Products Inc ("TAP"), its 50-50 joint venture with Abbott Laboratories, submitted a New Drug Application ("NDA") on December 14 with the US Food and Drug Administration for febuxostat 80mg and 120mg for the management of hyperuricemia in patients with chronic gout... click link for more info.

© Medical News Today